Amzak Health — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Nervoniknervonik.com inApr 2026 · $52.5M

Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.

HardwareHealthtechMedical Devices

Co-investorsFoothill Ventures Joyance Partners Lumira Ventures ShangBay Capital LLC US Venture Partners U.S. Venture Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.